PNC FINANCIAL SERVICES GROUP, INC. - PEREGRINE PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$1,0000.0%1,0000.0%0.00%
Q1 2017$1,0001,0000.0%0.00%
Q4 2016$01,0000.0%0.00%
Q3 2016$01,0000.0%0.00%
Q2 2016$01,0000.0%0.00%
Q1 2016$0
-100.0%
1,0000.0%0.00%
Q4 2015$1,0000.0%1,0000.0%0.00%
Q3 2015$1,0001,000
+2400.0%
0.00%
Q3 2014$0
-100.0%
40
-99.3%
0.00%
Q2 2014$11,0000.0%6,040
+0.7%
0.00%
Q1 2014$11,0006,0000.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
BAXTER BROS INC 170,506$232,0000.09%
First Heartland Consultants, Inc. 86,204$117,0000.05%
Rotella Capital Management, Inc. 20,769$28,0000.03%
FIDGEON TIMOTHY F 33,000$45,0000.02%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 547,800$746,0000.02%
Freedom Investment Management, Inc. 74,127$101,0000.02%
Investors Capital Advisory Services 63,288$86,0000.02%
REYNOLDS CAPITAL MANAGEMENT LLC 10,000$14,0000.01%
Tower Research Capital LLC (TRC) 76,914$104,0000.01%
PINNACLE FINANCIAL PARTNERS INC 20,000$27,0000.01%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders